Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 126 entries
View as:

MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04327063 Org: User:
Start: 08/04/20 End: 01/28/22 Due: 01/28/23

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT01373710 Org: User:
Start: 05/19/11 End: 04/09/18 Due: 04/09/19

Study of Tumor and Blood Samples From Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00897728 Org: User:
Start: 02/29/08 End: - Due: -

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Phase: N/A Priority: Normal
NCT ID: NCT02874040 Org: User:
Start: 04/19/13 End: 10/24/24 Due: 10/24/25

Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

Phase: N/A Priority: Normal
NCT ID: NCT02870907 Org: User:
Start: 03/31/10 End: 09/30/30 Due: 09/30/31

Impact of Forearm Free Flap in Orbital Exenteration Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT05255315 Org: User:
Start: 11/10/21 End: 11/10/22 Due: 11/10/23

Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05932667 Org: User:
Start: 10/12/23 End: 11/30/23 Due: 11/30/24

Early Detection of Triple Negative Breast Cancer Relapse

Phase: N/A Priority: Normal
NCT ID: NCT06225505 Org: User:
Start: 06/30/24 End: 12/15/28 Due: 12/15/29

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Phase: N/A Priority: Normal
NCT ID: NCT04478175 Org: User:
Start: 04/29/21 End: 10/05/22 Due: 10/05/23

Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

Phase: N/A Priority: Normal
NCT ID: NCT04681417 Org: User:
Start: 03/25/21 End: 01/20/36 Due: 01/20/37

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Phase: N/A Priority: Normal
NCT ID: NCT03017573 Org: User:
Start: 01/06/17 End: 01/06/32 Due: 01/06/33

The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)

Phase: N/A Priority: Normal
NCT ID: NCT04604873 Org: User:
Start: 09/28/20 End: 01/23/25 Due: 01/23/26

Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06175390 Org: User:
Start: 03/27/24 End: 02/15/29 Due: 02/15/30

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.

Phase: N/A Priority: Normal
NCT ID: NCT05439005 Org: User:
Start: 12/07/22 End: 03/15/26 Due: 03/15/27

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)

Phase: N/A Priority: Normal
NCT ID: NCT05558644 Org: User:
Start: 08/03/23 End: 10/05/26 Due: 10/05/27

First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)

Phase: N/A Priority: Normal
NCT ID: NCT04733027 Org: User:
Start: 05/18/21 End: 12/31/25 Due: 12/31/26

Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study

Phase: N/A Priority: Normal
NCT ID: NCT06073548 Org: User:
Start: 10/01/23 End: 04/01/26 Due: 04/01/27

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00957411 Org: User:
Start: 03/31/09 End: 10/31/14 Due: 10/31/15

Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04469205 Org: User:
Start: 10/05/20 End: 03/08/24 Due: 03/08/25

Breast Cancer Risk After Diagnostic Gene Sequencing

Phase: N/A Priority: Normal
NCT ID: NCT04145817 Org: User:
Start: 10/22/19 End: 03/03/22 Due: 03/03/23

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

Phase: N/A Priority: Normal
NCT ID: NCT02849145 Org: User:
Start: 09/30/14 End: 02/25/20 Due: 02/25/21

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

Phase: N/A Priority: Normal
NCT ID: NCT02866149 Org: User:
Start: 07/31/15 End: 09/30/24 Due: 09/30/25

Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation

Phase: N/A Priority: Normal
NCT ID: NCT02854293 Org: User:
Start: 05/31/12 End: 05/31/15 Due: 05/31/16

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)

Phase: N/A Priority: Normal
NCT ID: NCT03026998 Org: User:
Start: 03/19/17 End: 03/31/34 Due: 03/31/35

Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology

Phase: N/A Priority: Normal
NCT ID: NCT02220556 Org: User:
Start: 12/31/10 End: 12/31/17 Due: 12/31/18